STAT

Opinion: Graduate biomedical education needs an overhaul. Here’s our version

We need new ways to provide a steady supply of creative, dedicated scientists. Our initiative offers a new model for doing that.
Graduate biomedical education hasn't changed all that much since the 1800s. It needs a reboot.

One of the great educational success stories is that graduate training can teach individuals how to do deep scientific investigation. Today, such training, which dates back to the middle of the 19th century, is in desperate need of an overhaul.

The amount of scientific knowledge has exploded, giving rise to new fields in science with differing concepts, tools, and cultures. The training of new scientists has become a highly specialized endeavor that frequently emphasizes the acquisition of factual knowledge instead of skills that are essential for good scientific practice, such as critical thinking, rigorous research design, analysis, and philosophy of science. Many training programs today turn out young scientists with overly narrow interests and

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks